“…In vitro, ginsenosides treatment was demonstrated to increase survival and promote neurite growth in dopaminergic cells (Radad et al, 2004a), increase neurite growth in the presence of sub-optimal doses of nerve growth factor (Rudakewich et al, 2001), protect against PCB 52 induced apoptotic cell death (Lee et al, 2003), protect cells against glutamate toxicity (Radad et al, 2004b) and against ultraviolet-B induced apoptosis (Lee et al, 2003). In vivo, ginsenosides treatment was shown to reduce hypoxic brain injury in rats (Park et al, 2004), improve recovery in a model of ischemic brain injury (Park et al, 2004) and in a model of traumatic brain injury (Ji et al, 2005), to protect against toxic interventions in two models of Parkinson disease (Van Kampen et al, 2003) and against methamphetamine toxicity (Wu et al, 2003). A recent study that examined the effects of whole ginseng extract in a number of animal models of affective-like behavior did not find any specific antidepressantlike effects (Einat, 2007a) but most work related to the activity of ginseng to promote cellular resilience was done using active ingredients and not whole plant extract.…”